Joseph Frattaroli
Geen lopende functies
Vermogen: 15 229 $ op 30-04-2024
Loopbaan van Joseph Frattaroli
Eerdere bekende functies van Joseph Frattaroli
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INHIBIKASE THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-04-2018 | 31-03-2024 |
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Financieel Directeur/CFO | 24-12-2009 | 06-11-2012 |
President | 01-06-2003 | 06-11-2012 | |
Flagship Consulting, Inc. | Oprichter | 01-01-2010 | - |
Opleiding van Joseph Frattaroli
Salem State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Director of Finance/CFO | 2 |
President | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INHIBIKASE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
Flagship Consulting, Inc. |
- Beurs
- Insiders
- Joseph Frattaroli
- Ervaring